US Drug Recall Register

Is Chloride recalled?

Yes — there is an active recall. 326 ongoing FDA recalls mention Chloride (1,994 total). Check the affected lots below.

Recalls are matched by product description. A recall usually affects specific lots, not every package of Chloride. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed.

Class II · Moderate risk Terminated

children's allergy relief

Reason Failed Impurities/Degradation Specifications: unknown impurity higher than the specified limit was detected during routine stability testing.

Taro Pharmaceuticals U.S.A., Inc. D-0278-2019
Class II · Moderate risk Terminated

children's allergy

Reason Failed Impurities/Degradation Specifications: unknown impurity higher than the specified limit was detected during routine stability testing.

Taro Pharmaceuticals U.S.A., Inc. NDC 56062-106-08 D-0277-2019
Class II · Moderate risk Terminated

Children's 24 Hour Allergy

Reason Failed Impurities/Degradation Specifications: unknown impurity higher than the specified limit was detected during routine stability testing.

Taro Pharmaceuticals U.S.A., Inc. NDC 41250-106-08 D-0276-2019
Class II · Moderate risk Terminated

HydrOXYzine HYDROCHLORIDE SYRUP

Reason CGMP Deviations: cleaning procedures during manufacturing caused out of specification results for unknown impurities.

Lannett Company, Inc. NDC 54838-502-80 D-0083-2019
Class II · Moderate risk Terminated

0.9% Sodium Chloride Injection

Reason Lack of Assurance of Sterility; bags have the potential to leak

ICU Medical Inc NDC 0409-7983-02 D-0216-2019
Class II · Moderate risk Terminated

0.9% Sodium Chloride for Injection

Reason Lack of Assurance of Sterility

Pharm D Solutions, LLC NDC 69699-1426-10 D-0187-2019
Class III · Low risk Terminated

Bupropion Hydrochloride ER Tablets

Reason Failed impurities/ degradation specifications: Out-of-specification results were observed in the meta-chlorobenzoic acid impurity in batches 18 months or older from date of manufacture in the 90 count bottle size.

InvaGen Pharmaceuticals, Inc. NDC 69097-875-05 D-1212-2018
Class III · Low risk Terminated

Pramipexole dihydrochloride extended release tablets

Reason Failed impurities/degradation specifications: Finished product contain a known product impurity about current specification levels.

Par Pharmaceutical, Inc. NDC 10370-252-11 D-1185-2018
Class II · Moderate risk Terminated

Synjardy

Reason Cross Contamination With Other Products:

Boehringer Ingelheim Pharmaceuticals, Inc. NDC 0597-0175-18 D-1217-2018
Class II · Moderate risk Terminated

Metformin Hydrochloride Extended Release Tablets 1000 mg

Reason Defective Delivery System: There is a potential for some tablets to be missing the laser drilling which might affect drug release.

Teva Pharmaceuticals USA NDC 00591-2412-19 D-0101-2019
Class II · Moderate risk Terminated

Metformin Hydrochloride Extended Release Tablets 1000 mg

Reason Defective Delivery System: There is a potential for some tablets to be missing the laser drilling which might affect drug release.

Teva Pharmaceuticals USA NDC 00591-2720-60 D-0100-2019
Class II · Moderate risk Terminated

Metformin Hydrochloride Extended Release Tablets

Reason Defective Delivery System: There is a potential for some tablets to be missing the laser drilling which might affect drug release.

Teva Pharmaceuticals USA NDC 00591-2411-01 D-0099-2019
Class II · Moderate risk Terminated

Rexall

Reason CGMP Deviations: products manufactured under conditions that could impact its product quality.

Product Quest Manufacturing LLC D-0078-2019
Class II · Moderate risk Terminated

Rexall

Reason CGMP Deviations: products manufactured under conditions that could impact its product quality.

Product Quest Manufacturing LLC D-0077-2019
Class II · Moderate risk Terminated

Rexall

Reason CGMP Deviations: products manufactured under conditions that could impact its product quality.

Product Quest Manufacturing LLC D-0076-2019
Class II · Moderate risk Terminated

Best Choice

Reason CGMP Deviations: products manufactured under conditions that could impact its product quality.

Product Quest Manufacturing LLC D-0059-2019
Class II · Moderate risk Terminated

Best Choice

Reason CGMP Deviations: products manufactured under conditions that could impact its product quality.

Product Quest Manufacturing LLC D-0058-2019
Class II · Moderate risk Terminated

Best Choice

Reason CGMP Deviations: products manufactured under conditions that could impact its product quality.

Product Quest Manufacturing LLC D-0057-2019
Class II · Moderate risk Terminated

Best Choice

Reason CGMP Deviations: products manufactured under conditions that could impact its product quality.

Product Quest Manufacturing LLC D-0056-2019
Class II · Moderate risk Terminated

Rite Aid Pharmacy

Reason CGMP Deviations: products manufactured under conditions that could impact its product quality.

Product Quest Manufacturing LLC D-0051-2019
Class II · Moderate risk Terminated

QC Quality Choice

Reason CGMP Deviations: products manufactured under conditions that could impact its product quality.

Product Quest Manufacturing LLC D-0050-2019
Class II · Moderate risk Terminated

Premier Value

Reason CGMP Deviations: products manufactured under conditions that could impact its product quality.

Product Quest Manufacturing LLC NDC 68016-388-00 D-0048-2019